Skip to main content
SpringerLink
Log in

Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Background The effect of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and endothelial Nitric Oxide synthase (eNOS) gene G894 → T on vascular disease in end-stage renal disease (ESRD) patients was rarely studied previously. We investigated such effect in a Chinese population. Methods A total of 153 ESRD patients with vascular disease (88 men and 65 women; mean age ± SD: 54.0 ± 13.2) were recruited. Polymerase chain reaction was used to classify the ACE genotypes as II, ID and DD and the eNOS genotypes as GG, GT, and TT. Analyses were performed in ESRD patients with vascular disease (n = 153) and the age-matched controls (n = 148). Results The frequencies of ACE DD and eNOS TT genotypes and ACE D and eNOS T alleles in ESRD patients with vascular disease were significantly higher than those in the controls (P < 0.05). There was a significant interaction between ACE I/D alleles and eNOS G894 → T polymorphism: adjusted odds ratio 2.128 (95%CI 1.022–4.434, P = 0.017). Conclusions These results indicated that the etiology of vascular disease in ESRD patients is associated with ACE and eNOS (G894 → T) gene polymorphisms. Our data also suggest that an interaction effect may exist between ACE (I/D) and eNOS (G894 → T) polymorphism in increasing the risk of vascular complications in ESRD patients

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lindner A, Charra B, Sherrard DJ et al (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701

    PubMed  CAS  Google Scholar 

  2. Rostand SG, Brunzell JD, Cannon ROIII et al (1991) Cardiovascular complications in renal failure. J Am Soc Nephrol 2:1053–1062

    PubMed  CAS  Google Scholar 

  3. Zoccali C, Mallamaci F, Tripepi G (2004) Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15(Suppl 1):S77–S80. doi:10.1097/01.ASN.0000093240.84097.FE

    Article  PubMed  Google Scholar 

  4. Kimura H, Gejyo F, Yamaguchi T et al (1999) A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients. J Am Soc Nephrol 10:294–299

    PubMed  CAS  Google Scholar 

  5. Cambien F, Poirier O, Lecerf L et al (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641–644. doi:10.1038/359641a0

    Article  PubMed  CAS  Google Scholar 

  6. Samani NJ, Thompson JR, O’Toole L et al (1996) A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial. infarction. Circulation 94:708–712

    PubMed  CAS  Google Scholar 

  7. Staessen JA, Wang JG, Ginocchio G et al (1997) The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15:1579–1592. doi:10.1097/00004872-199715120-00059

    Article  PubMed  CAS  Google Scholar 

  8. Harden PN, Geddes C, Rowe PA et al (1995) Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345:540–1542. doi:10.1016/S0140-6736(95)91088-3

    Article  Google Scholar 

  9. Hunley TE, Julian BA, Phillips JA et al (1996) Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571–577. doi:10.1038/ki.1996.81

    Article  PubMed  CAS  Google Scholar 

  10. McLaughlin KJ, Harden PN, Ueda S et al (1996) The role of genetic polymorphisms of angiotensin converting enzyme in the progression of renal diseases. Hypertension 28:912–915

    PubMed  CAS  Google Scholar 

  11. Hadjadj S, Belloum R, Bouhanick B et al (2001) Prognostic value of angiotensin I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 12:541–549

    PubMed  CAS  Google Scholar 

  12. Yildiz A, Akkaya V, Hatemi AC et al (2000) No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron 84:130–135. doi:10.1159/000045560

    Article  PubMed  CAS  Google Scholar 

  13. Landmesser U, Hornig B, Drexler H (2004) Endothelial function-a critical determinant in atherosclerosis? Circulation 109(Suppl II):II27–II33. doi:10.1161/01.CIR.0000129501.88485.1f

    PubMed  Google Scholar 

  14. Paradossi U, Ciofini E, Clerico A et al (2004) Endothelial function and carotid intimamedia thickness in young healthy subjects among endothelial nitric oxide synthase Glu298Asp and T-786C polymorphisms. Stroke 35:1305–1309. doi:10.1161/01.STR.0000126482.86708.37

    Article  PubMed  Google Scholar 

  15. Naber CK, Baumgart D, Altmann C et al (2001) eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol 281:1908–1912

    Google Scholar 

  16. Rossi GP, Taddei S, Virdis A et al (2004) The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 41:938–945. doi:10.1016/S0735-1097(02)03011-5

    Article  Google Scholar 

  17. Casas JP, Bautista LE, Humphries SE et al (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease. Circulation 109:1359–1365. doi:10.1161/01.CIR.0000121357.76910.A3

    Article  PubMed  CAS  Google Scholar 

  18. Miyamoto Y, Saito Y, Kajiyama N et al (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3–8

    PubMed  CAS  Google Scholar 

  19. Lembo G, De LN, Battagli C et al (2001) A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735–740

    PubMed  CAS  Google Scholar 

  20. Nagase S, Suzuki H, Wang Y et al (2003) Association of eNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113–118. doi:10.1023/A:1022473405275

    Article  PubMed  CAS  Google Scholar 

  21. Nishimura H, Tsuji H, Masuda H et al (1999) The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost 82:1516–1521

    PubMed  CAS  Google Scholar 

  22. Boulanger CM, Caputo L, Levy BI (1995) Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 26:752–757

    PubMed  CAS  Google Scholar 

  23. Ikeda U, Maeda Y, Kawahara Y et al (1995) Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92:2683–2689

    PubMed  CAS  Google Scholar 

  24. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012. doi:10.1056/NEJM199312303292706

    Article  PubMed  CAS  Google Scholar 

  25. Berdeli A, Sekuri C, Cam FS et al (2005) Association between the eNOS(Glu298ASP) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 351:87–94. doi:10.1016/j.cccn.2004.08.015

    Article  PubMed  CAS  Google Scholar 

  26. Ruggenenti P, Perna A, Zoccali C et al (2000) Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. J Am Soc Nephrol 11:88–96

    PubMed  CAS  Google Scholar 

  27. Page A, Reich H, Zhou J et al (2005) Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 16:3053–3060. doi:10.1681/ASN.2004110905

    Article  PubMed  CAS  Google Scholar 

  28. Cambien F, Poirier O, Lecerf L et al (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641–644. doi:10.1038/359641a0

    Article  PubMed  CAS  Google Scholar 

  29. Rigat B, Hubert C, Alhene-Gelas F et al (1990) An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346. doi:10.1172/JCI114844

    Article  PubMed  CAS  Google Scholar 

  30. Osono E, Kurihara S, Hayama N et al (1998) Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 32:725–730. doi:10.1016/S0272-6386(98)70126-X

    Article  PubMed  CAS  Google Scholar 

  31. Tseng CH, Tseng CP, Chong CK et al (2007) Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan. Eur J Clin Invest 37:483–491. doi:10.1111/j.1365-2362.2007.01813.x

    Article  PubMed  CAS  Google Scholar 

  32. Tseng CH, Tseng CP (2002) Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan. Circ J 66:1014–1018. doi:10.1253/circj.66.1014

    Article  PubMed  CAS  Google Scholar 

  33. Wang XI, Sim AS, Wang MX et al (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471:45–50. doi:10.1016/S0014-5793(00)01356-9

    Article  PubMed  CAS  Google Scholar 

  34. Persu A, Stoenoiu MS, Messiaen T et al (2002) Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11:229–241. doi:10.1093/hmg/11.3.229

    Article  PubMed  CAS  Google Scholar 

  35. Veldman BA, Spiering W, Doevendans PA et al (2002) The Glu298Asp polymorphism of the NOS3 gene as a determinant of baseline production of nitric oxide. J Hypertens 20:2023–2027. doi:10.1097/00004872-200210000-00022

    Article  PubMed  CAS  Google Scholar 

  36. Nagase S, Suzuki H, Wang Y et al (2003) Association of eNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113–118. doi:10.1023/A:1022473405275

    Article  PubMed  CAS  Google Scholar 

  37. Noiri E, Satoh H, Taguchi J et al (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40:535–540. doi:10.1161/01.HYP.0000033974.57407.82

    Article  PubMed  CAS  Google Scholar 

  38. Spoto B, Benedetto FA, Testa A et al (2005) Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease. Am J Hypertens 18:1549–1555. doi:10.1016/j.amjhyper.2005.06.007

    Article  PubMed  CAS  Google Scholar 

  39. Zintzaras E, Kitsios G, Stefanidis I (2006) Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48(4):700–710. doi:10.1161/01.HYP.0000238124.91161.02

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Postdoctoral Scientific and technological Project of Hunan Province.

Author information

Authors and Affiliations

  1. Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

    Feng-Ying Tang & Fu-You Liu

  2. Department of Geriatrics, Xiang Ya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

    Xiong-Wei Xie

Authors
  1. Feng-Ying Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fu-You Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiong-Wei Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Feng-Ying Tang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, FY., Liu, FY. & Xie, XW. Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem 319, 33–39 (2008). https://doi.org/10.1007/s11010-008-9874-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-008-9874-6

Keywords

Search

Navigation